Advances in precision medicine are not currently available to all patients, especially those being treated in community cancer settings. This growing gap is challenging community health¬care systems to provide cost-effective, scalable, and innovative solutions for underserved patients.
This case study from Qiagen discusses how Protean BioDiagnostics partnered with Qiagen Digital Insights to develop a proprietary, multiomic, datacentric diagnostic guidance system to deploy whole-exome sequencing into clinical practice and give oncologists and practitioners access to the latest evidence-based diagnostics, therapeutics, and new clinical trials.
Offered Free by: Qiagen
See All Resources from: Qiagen